Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_assertion description "[PP2A activator FTY720 has been shown to possess the anti-leukemic activity for chronic myelogenous leukemia (CML), however, the cell killing mechanism underlying its anti-leukemic activity has remained to be verified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_assertion evidence source_evidence_literature NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_assertion SIO_000772 23851982 NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_assertion wasDerivedFrom befree-2016 NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_assertion wasGeneratedBy ECO_0000203 NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1093691.RAbkHM1LTlvWfJplHH2864p0FfwUZDJ6eJZA4_RyBw2xM130_provenance.